Advanced search
Publication Cover
International Review of Psychiatry Volume 14, 2002 - Issue 4: Recovery from schizophrenia: a challenge for the 21st century
Submit an article Journal homepage
248
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Multiple dimensions of recovery in early psychosis

D. Whitehorn Early Psychosis Program, Dalhousie University Department of Psychiatry and the Nova Scotia Hospital, Halifax,Nova Scotia, Canada
,
J. Brown Early Psychosis Program, Dalhousie University Department of Psychiatry and the Nova Scotia Hospital, Halifax,Nova Scotia, Canada
,
J. Richard Early Psychosis Program, Dalhousie University Department of Psychiatry and the Nova Scotia Hospital, Halifax,Nova Scotia, Canada
,
Q. Rui Early Psychosis Program, Dalhousie University Department of Psychiatry and the Nova Scotia Hospital, Halifax,Nova Scotia, Canada
&
L. Kopala Early Psychosis Program, Dalhousie University Department of Psychiatry and the Nova Scotia Hospital, Halifax,Nova Scotia, Canada
Pages 273-283 | Published online: 11 Jul 2009

  • AMERICAN PSYCHIATRIC ASSOCIATION. (1994). DSMIV: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association.
  • AMERICAN PSYCHIATRIC ASSOCIATION. (1997). Practice guidelines for the treatment of clients with schizophrenia. American Journal of Psychiatry, 154 (supplement).
  • ANTHONY, W-A. (1993). Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosocial Rehabilitation Journal, 16, 11-23.
  • BILDER, R.M., GOLDMAN, R.S., ROBINSON, D., REITER, G., BELL, L., BATES, J.A., PAPPANDOPULOS, E., WILLSON, D.F., ALVIR, J.M., WOERNER, M.G., GEISLER, S., KANE, J.M. & LIEBERMAN, J.A. (2000). Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549-559.
  • BIRCHWOOD, M., FOWLER, D. & JACKSON, C. (2001). Early interventton in psychosis: a guide to concepts, evidence and interventions. New York: Wiley & Sons.
  • BLACK, K., PETERS, L., RUI, Q., MILLIKEN, H., WHITEHORN, D. & KOPALA, L.C. (2001). Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophrenia Research, 47, 215-222.
  • BROWN, J.A., WHITEHORN, D, RICHARD, J., RUI, Q. & KOPALA, L.C. (2001). Association of premorbid adjustment at age twelve mat global functional outcome at two-year follow-up: initial results from the Nova Scotia Early Psychosis Program. Poster presented at the International Congress on Schizophrenia Research.
  • CANADIAN ASSOCIATION OF OCCUPATIONAL THERAPISTS. (1997). Enabling occupation: an occupational therapy perspective. Ottawa: CAOT Publications.
  • CANADIAN PSYCHIATRIC ASSOCIATION. (1998). Canadian clinical practice guidelines for the treatment of schizophrenia. The Canadian Journal of Psychiatry, 43 (Suppl), 25s-40s.
  • COLLABORATIVE WORKING GROUP ON CLINICAL TRIAL EVALUATIONS. (1998). Assessing the effects of atypical antipsychotics on negative symptoms. Journal of Clinical Psychiatry, 59 (Suppl 12), 28-34.
  • CRAIG, J., BROMET, E.J., PENNING, S., TANENBERGKARANT, M., LAVELLE, J. & GALAMBOS, N. (2000). Is there an association between duration of untreated psychosis and 24-month clinical outcome in a firstadmission series? American Journal of Psychiatry, 157, 60-66.
  • CROWN, M., WHITEHORN, L., MILLIKEN, H., DAVIDSON, C., WHITEHORN, D. & KOPALA, L.L (2001). Evaluating family psycho-education in early psychosis: the Nova Scotia Early Psychosis Program (NSEPP) experience. Presentation at International Congress on Schizophrenia Research.
  • DEEGAN, P. (1988). Recovery: the lived experience of rehabilitation. Psychosocial Rehabilitation Journal, 11, 11-19.
  • DICKERSON, F.B. (1997). Assessing clinical outcomes: the community functioning of persons with serious mental illness. Psychiatric Services, 48, 897-902.
  • DECON, L., POSTRADO, L., DELAHANTY, J., FISCHER, P., LEHMAN, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous & Mental Disease, 187, 496-502.
  • DRAKE, R.J., HALEY, C.J., AKHTAR, S. & LEWIS, S.W. (2000). Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511-515.
  • FISHER, A.G. (1999). Assessment of motor and process skills (3rd Edition). Colorado:Three Star Press.
  • GOLDMAN, H.H., SKODOL, A.E. & LAVE, TR. (1992). Revising Axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry, 149, 1148-1156.
  • GREEN, M.F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153,321-330.
  • HAFNER, H., LOFFLER, W, MAURER, K., HAMBRECHT, M. & HEIDEN, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100,105-118.
  • JONES, S.H., THORNICROFT, G., COFFEY, M. & DUNN, G. (1995). A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry, 166, 654-659.
  • KANE, J., HONIGFELD, G., SINGER, J. & MELTZER, H. (1988). Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
  • KAY, S.R., FISZBEIN, A. & OPLER, L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-267.
  • KOPALA, L. C., FREDRIKSON, D, GOOD, K.P. & HORNER, WG. (1996). Symptoms in neuroleptic-naive, firstepisode schizophrenia: response to risperidone. Biological Psychiatry, 39,296-298.
  • KOPELOWICZ, A., ZARATE, R., TRIPODIS, K., GONZALEZ,V.,MINTZ, J. (2000). Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. American Journal of Psychiatry, 157, 987-993.
  • LARSEN, T.K., JOHANNESSEN, J.O., GULDBERG, C., OPJORDSMOEN, S., VAGLUM, P., MCGLASHAN, TH. (1999). Early intervention programs in first-episode psychosis and reduction of duration of untreated psychosis (DUP). Schizophrenia Research, 36,344.
  • LARSEN5TK., McGLASHAN5TH. & MOB, L.C. (1996).First-episode schizophrenia: I. Early course parameters. Schizophrenia Bulletin, 22,241-256.
  • LARSEN, TK., MOE, L.C., VIBE-HANSEN, L. & JOHANNESSEN, J.O. (2000). Premorbid functioning versus duration of untreated psychosis in 1-year outcome in first-episode psychosis. Schizophrenia Research, 45,1-9.
  • LAW, M., BAPTISTE, S., CARSWELL, A., McCOLL, M.A., POLATAJKO, H. & POLLOCK, N. (1998). Canadian Occupational Performance Measure (3rd Edition). Ottawa: CAOT Publications ACE.
  • LBHMAN, A.F., CARPENTER, W.T., GOLDMAN, H.H. & STEINWACHS, D.M. (1995). Treatment outcomes in schizophrenia: implications for practice, policy, and research. Schizophrenia Bulletin, 21, 669-675.
  • LJBERMAN, R.P., KOPELOWICZ, A., VENTURA, J. & GUTKIND, D. (2002). Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry, 14, 256-272.
  • LIEBERMAN, J.A. & FENTON,W.S. (2000). Delayed detection of psychosis: causes, consequences and effect on public health. American Journal of Psychiatry, 157, 1727-1730.
  • LIEBERMAN, J., JODY, D., GEISLER, S., ALVIR, J., LOEBEL, A., SZYMANSKI, S., WOERNER, M. & BORENSTEIN, M. (1993). Time course and biological correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry, 50, 369-376.
  • LINDENMAYER, J.P., GROCHOWSKI, S. & HYMAN, R.B. (1995). Five factor model of schizophrenia: replication across samples. Schizophrenia Research, 14, 229-234.
  • MCGLASHAN, T.H. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biological Psychiatry, 46, 899-907.
  • MCGORRY, P.D. & JACKSON, H.J. (1999). The recognition and management of early psychosis: a preventative approach. Cambridge: Cambridge Press.
  • MCGORRY, P.D., PHILLIPS, L.J. YUNG, A.R., FRANCEY, S., GERMANO, D, BRAVIN, J., MACDONALD, A., HEARN, N., AMMINGER, P. & O'DWYER, L. (2000). Does early non-pharmacologic intervention alter the course of schizophrenia: a randomized controlled trial of interventions in the pre-psychotic phase of psychotic disorders. Schizophrenia Research, 41, 9.
  • MOLLER, H.J., MULLER, H., BORISON, R.L., SCHOOLER, N.R. & CHOUINARD, G. (1995). A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study. European Archives of Psychiatry & Clinical Neuroscience, 245, 45-49.
  • NATIONAL EARLY PSYCHOSIS PROJECT CLINICAL GUIDELINES WORKING PARTY. (1998). Australian clinical guidelines for early psychosis. Melbourne: National Early Psychosis Project, University of Melbourne.
  • RICHARD, J., WHITEHORN, D. & KOPALA, L. (2001). Health outcomes among newly diagnosed clients with schizophrenia and related disorders in the Province of Nova Scotia, Canada. Presentation at the International Congress on Schizophrenia Research.
  • ROY-BYRNE, P., DAGADAKIS, C., UNUTZER, J. & RIES, R. (1996). Evidence for limited validity of the revised Global Assessment of Functioning Scale. Psychiatric Services, 47, 864-866.
  • SINGH, S.P., CROUDACE, T, AMIN, S., KWEICINSKI, R., MEDLEY, L, JONES, P.B. & HARRISON, G. (2000). Three-year outcome of first-episode psychoses in an established community psychiatry service. British Journal of Psychiatry, 176, 210-216.
  • STRAUSS, J.S., HAFEZ, H., LIEVERMAN, P. & HARDING, C.M. (1985). The course of psychiatric disorder III: longitudinal principles. American Journal of Psychiatry, 142,289-296.
  • TOLLEFSON, G.D. & SANGER, TM. (1997). Negative symptoms: a path analytical approach to a doubleblind, placebo and haloperidol controlled clinical trial with olanzapine. American Journal of Psychiatry, 154, 466-474.
  • VON KNORRING, L & LINDSTROM, E. (1998). Principal components and further possibilities with the PANSS. Ada Psychiatrica Scandtnavica, 388 (Suppl), 5-10.
  • WALLACE, C.J., LJBERMAN, R.P., TAUBER, R. & WALLACE, J. (2000). The Independent Living Skills Survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bulletin, 26, 631-658.
  • WHITE, L., HARVEY, P.D., OPLER, L. & LINDENMAYER, J.P. (1997). Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multi-site, multi-model evaluation of the factorial structure of the Positive and Negative Syndrome Scale. Psychpathology, 30, 263-274.
  • WHITEHORN, D., LAZIER, L & KOPALA, L (1998).Psychosocial rehabilitation early after the onset ofpsychosis. Psychiatric Services, 49, 1135-1137.
  • YUNG, A.R., PHILLIPS, L.J., MCGORRY, P.D., McFARLANE, C.A., FRANCEY, S., HARRIGAN, S., PATTON, G.G. & JACKSON, H.J. (1998). Prediction of psychosis.British Journal of Psychiatry, 172 (Suppl 33), 14-20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.